Saldívar GFM, Arellano AG, Aguirre TJ, Montoya CEA, Domínguez CLG

Language: Spanish
References: 16
Page: 400-405
PDF size: 289.54 Kb.

ABSTRACT

Introduction: Parathyroid cancer glands (PC) described by De Quervain in 1909 represents one of less frequent neoplasm; since PC is functionally active, the initial clinical behavior is similar to benign parathyroid neoplasms. Clinical case: A 49-year-old male who went to the emergency with nausea and vomiting of one week of evolution. On examination there was a left lobe of the thyroid gland increase in the volume, associated with hypercalcemia of 19 mg/dL and parathyroid hormone of 1,873 pg/mL, with a gammagram showed a functioning tumor located to the left inferior parathyroid gland; with previous ultrasound and tomography, he underwent surgery. The histopathological study reported parathyroid cancer, a radical surgery was performed in a second time, and radiotherapy was prescribed. Conclusions: PC represents the less frequent neoplasm; in patients with parathyroid hormone levels greater than 1,000 pg/mL and hypercalcemia greater than 14 mg/dL, this condition should be suspected.

REFERENCES

1. De Quervain VF. Parastruma maligna aberrata. Deut Zschr Chir. 1909; 100: 334-352.

2. Armstrong HG. Primary carcinoma of the parathyroid with report of a case. Bull Acad Med Tor. 1938; 11: 105-110.

3. Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004; 26 (8): 716-726.

4. Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005; 132 (3): 359-364.

5. Ozolins A, Narbuts Z, Vanags A, Simtniece Z, Visnevska Z, Akca A et al. Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism. Langenbecks Arch Surg. 2016; 401 (7): 943-948.

6. Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer. 2007; 109 (9): 1736-1741.

7. James BC, Aschebrook-Kilfoy B, Cipriani N, Kaplan EL, Angelos P, Grogan RH. The incidence and survival of rare cancers of the thyroid, parathyroid, adrenal, and pancreas. Ann Surg Oncol. 2016; 23 (2): 424-433.

8. Rubin MR, Silverberg SJ. Editorial: HRPT2 in parathyroid cancer: a piece of the puzzle. J Clin Endocrinol Metab. 2005; 90 (9): 5505-5507.

9. Owen RP, Silver CE, Pellitteri PK, Shaha AR, Devaney KO, Werner JA et al. Parathyroid carcinoma: a review. Head Neck. 2011; 33 (3): 429-436.

10. Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer. 1973; 31 (3): 600-605.

11. Quinn CE, Healy J, Lebastchi AH, Brown TC, Stein JE, Prasad ML et al. Modern experience with aggressive parathyroid tumors in a high-volume New England referral center. J Am Coll Surg. 2015; 220 (6): 1054-1062.

12. Landry CS, Wang TS, Asare EA et al. Parathyroid. In: Amin MB, Edge SB, American Joint Committee on Cancer.; Springer Science + Business Media.; AJCC Cancer Staging Manual. 8th, Amin MB (Ed), Springer, New York 2017. p. 903.

13. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. Between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1999; 86 (3): 538-544.

14. Clayman GL, Gonzalez HE, El-Naggar A, Vassilopoulou SR. Parathyroid carcinoma: evaluation and interdisciplinary management. Cancer. 2004; 100 (5): 900-905.

15. Munson ND, Foote RL, Northcutt RC, Tiegs RD, Fitzpatrick LA, Grant CS et al. Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer. 2003; 98 (11): 2378-2384.

16. Khan A, Bilezikian J, Bone H, Gurevich A, Lakatos P, Misiorowski W et al. Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery. Eur J Endocrinol. 2015; 172 (5): 527-535.